Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease

Conclusions
eNose technology can completely distinguish ILD patients from healthy controls and can accurately discriminate between different ILD subgroups. Hence, exhaled breath analysis using eNose technology could be a novel biomarker in ILD, enabling timely diagnosis in the future.

Source: European Respiratory Journal - January 5, 2021 Category: Respiratory Medicine Authors: Moor, C. C., Oppenheimer, J. C., Nakshbandi, G., Aerts, J. G. J. V., Brinkman, P., Maitland-van der Zee, A.-H., Wijsenbeek, M. S. Tags: Interstitial and orphan lung disease Original Articles: Interstitial lung disease Source Type: research